Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabi...
Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome
About this item
Full title
Author / Creator
NAKAMURA, R , RODRIGUEZ, R , KOGUT, N , PULLARKAT, V , KIRSCHBAUM, M , FORMAN, S. J , O'DONNELL, M. R , PALMER, J , STEIN, A , NAING, A , TSAI, N , CHANG, K , SLOVAK, M. L , BHATIA, R and SPIELBERGER, R
Publisher
Basingstoke: Nature Publishing Group
Journal title
Language
English
Formats
Publication information
Publisher
Basingstoke: Nature Publishing Group
Subjects
More information
Scope and Contents
Contents
We retrospectively evaluated the outcome of reduced-intensity conditioning (RIC) followed by allogeneic hematopoietic stem cell transplantation (HCT) in 43 patients with myelodysplastic syndrome (MDS) or AML arising from MDS. All patients received fludarabine plus melphalan followed by an allogeneic HCT from an HLA-identical sibling (SIB: n=19) or...
Alternative Titles
Full title
Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_20285660
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_20285660
Other Identifiers
ISSN
0268-3369
E-ISSN
1476-5365
DOI
10.1038/sj.bmt.1705801
